Icosahedral boron clusters as modifying entities for biomolecules

References

• Mirkin CA, Taton TA. Materials chemistry - semiconductors meet biology. Nature. 2000;405(6787):626–627.
   PubMed Web of Science ®Google Scholar
• Lesnikowski ZJ. Recent developments with boron as a platform for novel drug design. Expert Opin Drug Discov. 2016;11(6):569–578.
   PubMed Web of Science ®Google Scholar
• Lesnikowski ZJ. Challenges and opportunities for the application of boron clusters in drug design. J Med Chem. 2016;59(17):7738–7758.
   PubMed Web of Science ®Google Scholar
• Grimes RN. Carboranes. London: Academic Press; 2016.
   Google Scholar
• Gabel D. Boron clusters in medicinal chemistry: perspectives and problems. Pure Appl Chem. 2015;87(2):173–179.
   Web of Science ®Google Scholar
• Fernandez-Alvarez R, Dordovic V, Uchman M, et al. Amphiphiles without head-and-tail design: nanostructures based on the self-assembly of anionic boron cluster compounds. Langmuir. 2017. DOI:10.1021/acs.langmuir.7b03306.
   PubMed Web of Science ®Google Scholar
• Farras P, Juarez-Perez EJ, Lepsik M, et al. Metallacarboranes and their interactions: theoretical insights and their applicability. Chem Soc Rev. 2012;41(9):3445–3463.
   PubMed Web of Science ®Google Scholar
• Planas JG, Vinas C, Teixidor F, et al. Self-assembly of mercaptane-metallacarborane complexes by an unconventional cooperative effect: a C-H…S-H…H-B hydrogen/dihydrogen bond interaction. J Am Chem Soc. 2005;127(45):15976–15982.
   PubMed Web of Science ®Google Scholar
• Fanfrlik J, Lepsik M, Horinek D, et al. Interaction of carboranes with biomolecules: formation of dihydrogen bonds. ChemPhysChem. 2006;7(5):1100–1105.
   PubMed Web of Science ®Google Scholar
• Valliant JF, Guenther KJ, King AS, et al. The medicinal chemistry of carboranes. Coord Chem Rev. 2002;232(1–2):173–230.
   Web of Science ®Google Scholar
• Pitochelli AR, Hawthorne MF. The isolation of the icosahedral B12h12-2 ion. J Am Chem Soc. 1960;82(12):3228–3229.
   Web of Science ®Google Scholar
• Heying TL, Ager JW, Clark SL, et al. A new series of organoboranes 1. Carboranes from reaction of decaborane with acetylenic compounds. Inorg Chem. 1963;2(6):1089.
   Web of Science ®Google Scholar
• Fein MM, Mayes N, Cohen MS, et al. Carboranes .2. Preparation of 1- and 1,2-substituted carboranes. Inorg Chem. 1963;2(6):1115.
   Web of Science ®Google Scholar
• King RB. Three-dimensional aromaticity in polyhedral boranes and related molecules. Chem Rev. 2001;101(5):1119–1152.
   PubMed Web of Science ®Google Scholar
• Issa F, Kassiou M, Rendina LM. Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds. Chem Rev. 2011;111(9):5701–5722.
   PubMed Web of Science ®Google Scholar
• Sivaev IB, Bregadze VV. Polyhedral boranes for medical applications: current status and perspectives. Eur J Inorg Chem. 2009;2009(11):1433–1450.
   Web of Science ®Google Scholar
• Uchman M, Jurkiewicz P, Cigler P, et al. Interaction of fluorescently substituted metallacarboranes with cyclodextrins and phospholipid bilayers: fluorescence and light scattering study. Langmuir. 2010;26(9):6268–6275.
   PubMed Web of Science ®Google Scholar
• Hawthorne MF, Young DC, Wegner PA. Carbametallic boron hydride derivatives .I. Apparent analogs of ferrocene and ferricinium ion. J Am Chem Soc. 1965;87(8):1818.
   Web of Science ®Google Scholar
• Goszczynski TM, Fink K, Kowalski K, et al. Interactions of boron clusters and their derivatives with serum albumin. Sci Rep. 2017;7(1):9800.
   PubMedGoogle Scholar
• Uchman M, Dordovic V, Tosner Z, et al. Classical amphiphilic behavior of nonclassical amphiphiles: a comparison of metallacarborane self-assembly with SDS micellization. Angew Chem Int Ed Engl. 2015;54(47):14113–14117.
   PubMed Web of Science ®Google Scholar
• Bauduin P, Prevost S, Farras P, et al. A theta-shaped amphiphilic cobaltabisdicarbollide anion: transition from monolayer vesicles to micelles. Angew Chem Int Ed Engl. 2011;50(23):5298–5300.
   PubMed Web of Science ®Google Scholar
• Brusselle D, Bauduin P, Girard L, et al. Lyotropic lamellar phase formed from monolayered theta-shaped carborane-cage amphiphiles. Angew Chem Int Ed Engl. 2013;52(46):12114–12118.
   PubMed Web of Science ®Google Scholar
• Matejicek P, Cigler P, Olejniczak AB, et al. Aggregation behavior of nucleoside-boron cluster conjugates in aqueous solutions. Langmuir. 2008;24(6):2625–2630.
   PubMed Web of Science ®Google Scholar
• Locher GL. Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol Radi. 1936;36(1):1–13.
   Google Scholar
• Barth RF, Vicente MG, Harling OK, et al. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer. Radiat Oncol. 2012;7:146.
   PubMed Web of Science ®Google Scholar
• Moss RL. Critical review, with an optimistic outlook, on boron neutron capture therapy (BNCT). Appl Radiat Isot. 2014;88:2–11.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakai K, Matsumura A. Boron neutron capture therapy for glioblastoma. Cancer Lett. 2008;262(2):143–152.
   PubMed Web of Science ®Google Scholar
• Kabalka GW, Wu ZZ, Yao ML, et al. The syntheses and in vivo biodistribution of novel boronated unnatural amino acids. Appl Radiat Isot. 2004;61(5):1111–1115.
   PubMed Web of Science ®Google Scholar
• Semioshkin A, Laskova J, Ilinova A, et al. Reactions of oxonium derivatives of [B12H12](2-) with sulphur nucleophiles. Synthesis of novel B-12-based mercaptanes, sulfides and nucleosides. J Organomet Chem. 2011;696(2):539–543.
   Web of Science ®Google Scholar
• Barth RF, Yang W, Al-Madhoun AS, et al. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors. Cancer Res. 2004;64(17):6287–6295.
   PubMed Web of Science ®Google Scholar
• Al-Madhoun AS, Johnsamuel J, Barth RF, et al. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res. 2004;64(17):6280–6286.
   PubMed Web of Science ®Google Scholar
• Grin MA, Semioshkin AA, Titeev RA, et al. Synthesis of a cycloimide bacteriochlorin p conjugate with the closo-dodecaborate anion. Mendeleev Commun. 2007;17(1):14–15.
   Web of Science ®Google Scholar
• Semioshkin A, Tsaryova O, Zhidkova O, et al. Reactions of oxonium derivatives of (B12H12)(2-) with phenoles, and synthesis and photochemical properties of a phthalocyanine containing four (B12H12)(2-) groups. J Porphyrins Phthalocyanines. 2006;10(11):1293–1300.
   Web of Science ®Google Scholar
• Hawthorne MF, Maderna A. Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer. Chem Rev. 1999;99(12):3421–3434.
   PubMed Web of Science ®Google Scholar
• Mier W, Gabel D, Haberkorn U, et al. Conjugation of the closo-borane mereaptoundecahydrododecaborate (BSH) to a tumour selective peptide. Zeitschrift Fur Anorganische Und Allgemeine Chemie. 2004;630(8–9):1258–1262.
   Web of Science ®Google Scholar
• Yang W, Barth RF, Wu G, et al. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. Appl Radiat Isot. 2009;67(7–8 Suppl):S328–S331.
   PubMed Web of Science ®Google Scholar
• Nakamura H. Liposomal boron delivery for neutron capture therapy. Methods Enzymol. 2009;465:179–208.
   PubMed Web of Science ®Google Scholar
• Qian EA, Wixtrom AI, Axtell JC, et al. Atomically precise organomimetic cluster nanomolecules assembled via perfluoroaryl-thiol SNAr chemistry. Nat Chem. 2017;9(4):333–340.
   PubMed Web of Science ®Google Scholar
• Pushechnikov A, Jalisatgi SS, Hawthorne MF. Dendritic closomers: novel spherical hybrid dendrimers. Chem Commun. 2013;49(34):3579–3581.
   PubMed Web of Science ®Google Scholar
• Tafreshi NK, Lloyd MC, Bui MM, et al. Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases. Subcell Biochem. 2014;75:221–254.
   PubMedGoogle Scholar
• Mader P, Brynda J, Gitto R, et al. Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. J Med Chem. 2011;54(7):2522–2526.
   PubMed Web of Science ®Google Scholar
• Brynda J, Mader P, Sicha V, et al. Carborane-based carbonic anhydrase inhibitors. Angew Chem Int Ed Engl. 2013;52(51):13760–13763.
   PubMed Web of Science ®Google Scholar
• Mader P, Pecina A, Cigler P, et al. Carborane-based carbonic anhydrase inhibitors: insight into CAII/CAIX specificity from a high-resolution crystal structure, modeling, and quantum chemical calculations. Biomed Res Int. 2014;2014:389869.
   PubMed Web of Science ®Google Scholar
• Cigler P, Kozisek M, Rezacova P, et al. From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease. Proc Natl Acad Sci U S A. 2005;102(43):15394–15399.
   PubMed Web of Science ®Google Scholar
• Kozisek M, Cigler P, Lepsik M, et al. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. J Med Chem. 2008;51(15):4839–4843.
   PubMed Web of Science ®Google Scholar
• Rezacova P, Pokorna J, Brynda J, et al. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. J Med Chem. 2009;52(22):7132–7141.
   PubMed Web of Science ®Google Scholar
• Gona KB, Zaulet A, Gomez-Vallejo V, et al. COSAN as a molecular imaging platform: synthesis and “in vivo” imaging. Chem Commun (Camb). 2014;50(77):11415–11417.
   PubMed Web of Science ®Google Scholar
• Volovetsky AB, Shilyagina NY, Dudenkova VV, et al. Biodistribution of amine-amide chlorin e(6) derivative conjugate with a boron nanoparticle for boron neutron-capture therapy. Sovremennye Tehnologii V Medicine. 2016;8(1):34–39.
   Web of Science ®Google Scholar
• Tarres M, Canetta E, Paul E, et al. Biological interaction of living cells with COSAN-based synthetic vesicles. Sci Rep. 2015;5:7804.
   PubMed Web of Science ®Google Scholar
• Tarres M, Canetta E, Vinas C, et al. Imaging in living cells using nuB-H Raman spectroscopy: monitoring COSAN uptake. Chem Commun (Camb). 2014;50(25):3370–3372.
   PubMed Web of Science ®Google Scholar
• Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance. Nat Rev Microbiol. 2011;9(12):894–896.
   PubMed Web of Science ®Google Scholar
• Totani T, Aono K, Yamamoto K, et al. Synthesis and invitro antimicrobial property of ortho-carborane derivatives. J Med Chem. 1981;24(12):1492–1499.
   PubMed Web of Science ®Google Scholar
• Oros G, Ujvary I, Nachman RJ. Antimicrobial activity of o-carboranylalanine. Amino Acids. 1999;17(4):357–368.
   PubMed Web of Science ®Google Scholar
• Li S, Wang Z, Wei Y, et al. Antimicrobial activity of a ferrocene-substituted carborane derivative targeting multidrug-resistant infection. Biomaterials. 2013;34(4):902–911.
   PubMed Web of Science ®Google Scholar
• Li SH, Wu CY, Tang X, et al. New strategy for reversing biofilm-associated antibiotic resistance through ferrocene-substituted carborane ruthenium(II)-arene complex. Sci China Chem. 2013;56(5):595–603.
   Web of Science ®Google Scholar
• Wu C, Ye H, Bai W, et al. New potential anticancer agent of carborane derivatives: selective cellular interaction and activity of ferrocene-substituted dithio-o-carborane conjugates. Bioconjug Chem. 2011;22(1):16–25.
   PubMed Web of Science ®Google Scholar
• Adamska A, Rumijowska-Galewicz A, Ruszczynska A, et al. Anti-mycobacterial activity of thymine derivatives bearing boron clusters. Eur J Med Chem. 2016;121:71–81.
   PubMed Web of Science ®Google Scholar
• Kvasnickova E, Masak J, Cejka J, et al. Preparation, characterization, and the selective antimicrobial activity of N-alkylammonium 8-diethyleneglycol cobalt bis-dicarbollide derivatives. J Organomet Chem. 2017;827:23–31.
   Web of Science ®Google Scholar
• Zheng YK, Liu WW, Chen Y, et al. A highly potent antibacterial agent targeting methicillin-resistant staphylococcus aureus based on cobalt bis(1,2-Dicarbollide) alkoxy derivative. Organometallics. 2017;36(18):3484–3490.
   Web of Science ®Google Scholar
• Semioshkin AA, Sivaev IB, Bregadze VI. Cyclic oxonium derivatives of polyhedral boron hydrides and their synthetic applications. Dalton Trans. 2008;(8):977–992.
   PubMed Web of Science ®Google Scholar
• Sivaev IB, Semioshkin AA, Brellochs B, et al. Synthesis of oxonium derivatives of the dodecahydro-closo-dodecaborate anion [B12H12](2-). Tetramethylene oxonium derivative of [B12H12](2-) as a convenient precursor for the synthesis of functional compounds for boron neutron capture therapy. Polyhedron. 2000;19(6):627–632.
   Web of Science ®Google Scholar
• Wojtczak BA, Andrysiak A, Gruner B, et al. “Chemical ligation”: a versatile method for nucleoside modification with boron clusters. Chemistry (Easton). 2008;14(34):10675–10682.
   Web of Science ®Google Scholar
• Goszczynski TM, Kowalski K, Lesnikowski ZJ, et al. Solid state, thermal synthesis of site-specific protein-boron cluster conjugates and their physicochemical and biochemical properties. Biochim Biophys Acta. 2015;1850(2):411–418.
   PubMed Web of Science ®Google Scholar
• Kowalski K, Goszczynski T, Lesnikowski ZJ, et al. Synthesis of lysozyme-metallacarborane conjugates and the effect of boron cluster modification on protein structure and function. ChemBioChem. 2015;16(3):424–431.
   PubMed Web of Science ®Google Scholar
• Khan IU, Beck-Sickinger AG. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. Anticancer Agents Med Chem. 2008;8(2):186–199.
   PubMed Web of Science ®Google Scholar
• Ahrens VM, Frank R, Stadlbauer S, et al. Incorporation of ortho-carbaboranyl-N-epsilon-modified L-lysine into neuropeptide Y receptor Y-1- and Y-2-selective analogues. J Med Chem. 2011;54(7):2368–2377.
   PubMed Web of Science ®Google Scholar
• Frank R, Ahrens VM, Boehnke S, et al. Charge-compensated metallacarborane building blocks for conjugation with peptides. Chembiochem. 2016;17(4):308–317.
   PubMed Web of Science ®Google Scholar
• Betzel T, Hess T, Waser B, et al. closo-borane conjugated regulatory peptides retain high biological affinity: synthesis of closo-borane conjugated Tyr(3)-octreotate derivatives for BNCT. Bioconjug Chem. 2008;19(9):1796–1802.
   PubMed Web of Science ®Google Scholar
• Kimura S, Masunaga S, Harada T, et al. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy. Bioorg Med Chem. 2011;19(5):1721–1728.
   PubMed Web of Science ®Google Scholar
• Varadarajan A, Hawthorne MF. Novel carboranyl amino acids and peptides: reagents for antibody modification and subsequent neutron-capture studies. Bioconjug Chem. 1991;2(4):242–253.
   PubMed Web of Science ®Google Scholar
• Fischli W, Leukart O, Schwyzer R. Hormone-receptor interactions - carboranylalanine (Car) as a phenylalanine analog - reactions with chymotrypsin. Helv Chim Acta. 1977;60(3):959–963.
   PubMed Web of Science ®Google Scholar
• Eberle A, Leukart O, Schiller P, et al. Hormone-receptor interactions - [4-carboranylalanine, 5-leucine]-Enkephalin as a structural probe for opiate receptor. Febs Letters. 1977;82(2):325–328.
   PubMed Web of Science ®Google Scholar
• Nachman RJ, Teal PE, Radel PA, et al. Potent pheromonotropic/myotropic activity of a carboranyl pseudotetrapeptide analogue of the insect pyrokinin/PBAN neuropeptide family administered via injection or topical application. Peptides. 1996;17(5):747–752.
   PubMed Web of Science ®Google Scholar
• Couture R, Drouin JN, Leukart O, et al. Biological-activities of kinins and substance-P octapeptides (4-11) in which phenylalanine residues have been replaced with L-carboranylalanine. Can J Physiol Pharmacol. 1979;57(12):1437–1442.
   Web of Science ®Google Scholar
• Escher E, Guillemette G, Leukart O, et al. Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car). Eur J Pharmacol. 1980;66(4):267–272.
   PubMed Web of Science ®Google Scholar
• Ruff D, Crockford D, Girardi G, et al. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. Ann N Y Acad Sci. 2010;1194:223–229.
   PubMed Web of Science ®Google Scholar